An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with thousands of participants share comparison images, injection guides and assertions of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.
Several professionals stated the popularity for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.
Some content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer laws, risking fines, legal action or imprisonment.
Service Reaction and Material Removal
According to the social media company, the platform has taken down problematic material and banned related keywords and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.
Digital Trading Operations
Research also discovered groups with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed guides for preparing or injecting at home.
Within moments of entering one community, a seller shared WhatsApp details, where most transactions occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, health issues or previous experience.
Product Information and Pricing
Within these groups, messages show black plastic packages with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they cannot confirm. Even if the research behind retatrutide is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental product not yet approved … may subject users to potentially serious medical dangers”.
